ISRAEL: Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel, and the man credited with first discovering and isolating THC will keynote the 3rd International Medical Cannabis Conference (CannX), October 14-16th in Tel Aviv.

Speaking on The Plant Cannabinoids And The Endocannabinoid System — An Overview Of Research Over Five Decades, Dr. Mechoulam will set the stage for the two-day interactive science conference.  CannX was created as a interactive forum for top global leaders in all areas of medical cannabis to explore the latest scientific and clinical research, agricultural practices and innovation, and business opportunities in medical cannabis.

Joining Dr. Mechoulam in delivering keynote speeches will be Donald Abrams, Professor of Clinical Medicine at the University of California, Dr Kirsten R. Müller-Vahl Director of Tourette Syndrome Clinic at the Medical School of Hannover, Germany, and Prof. Michael Dixon Expert for the effects of Environmental on cannabis grow at School of Environmental Sciences, The University of Guelph, Canada.

CannX will feature research on:

• Dementia and Cannabis TreatmentUtilizing the “Entourage Effect” for the Alleviation of Sleep Disorder Symptoms
• What Is Known about Marijuana’s Potential Utility in Treating Tourette Syndrome?
• The Health Effects of Cannabis and Cannabinoids: Will Cannabis Cure Cancer?
• The Latest Space Exploration Life Support Technology Finds Applications in Medical Cannabis Production

Program Tracks: The scientific program includes three key areas of specialization and interest:

Follow this track and explore the latest scientific and clinical research.

Benefit from it if you are:

✓  Scientific Researcher
✓  Medical Practitioner
✓  Medical Cannabis Organization